SOAM
BSX icon

SBI Okasan Asset Management’s Boston Scientific BSX Stock Holding History

SBI Okasan Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Sell
9,420
-6,800
-42% -$369K 0.01% 237
2026
Q1 		$1.02M Sell
16,220
-3,016
-16% -$241K 0.04% 101
2025
Q4 		$1.84M Buy
+19,236
New +$1.89M 0.1% 48

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SBI Okasan Asset Management's BSX Position: Q2 2026 in Review

SBI Okasan Asset Management reduced its Boston Scientific (BSX) stake by 42% in Q2 2026, selling an estimated $369K and leaving 9,420 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #237.

SBI Okasan Asset Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.84M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SBI Okasan Asset Management held 9,420 shares of Boston Scientific worth $410K as of Q2 2026.
  • SBI Okasan Asset Management sold 6,800 Boston Scientific shares in Q2 2026, an estimated $369K.
  • Boston Scientific made up 0.01% of SBI Okasan Asset Management's portfolio in Q2 2026, its #237 holding.
  • SBI Okasan Asset Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • SBI Okasan Asset Management's Boston Scientific position peaked at $1.84M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.